as 05-31-2024 4:00pm EST
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | SUNNYVALE |
Market Cap: | 865.0M | IPO Year: | 2019 |
Target Price: | $20.89 | AVG Volume (30 days): | 644.2K |
Analyst Decision: | Hold | Number of Analysts: | 11 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.38 | EPS Growth: | N/A |
52 Week Low/High: | $6.08 - $34.13 | Next Earning Date: | 07-30-2024 |
Revenue: | $185,487,000 | Revenue Growth: | 23.04% |
Revenue Growth (this year): | 13.85% | Revenue Growth (next year): | 11.37% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Ruedy Richard | SILK | EVPClin&Reg.Affairs&QA | Mar 5 '24 | Sell | $17.17 | 3,800 | $65,242.20 | 205,711 | SEC Form 4 |
Ballinger Kevin J. | SILK | Director | Mar 5 '24 | Buy | $16.99 | 11,700 | $198,783.00 | 17,807 | SEC Form 4 |
Klemz Kevin M | SILK | EVP/Chief Legal Officer/Sec. | Mar 1 '24 | Sell | $17.17 | 2,497 | $42,870.99 | 165,194 | SEC Form 4 |
Ruedy Richard | SILK | EVPClin&Reg.Affairs&QA | Feb 29 '24 | Sell | $22.25 | 3,000 | $66,750.00 | 170,837 | SEC Form 4 |
SILK Breaking Stock News: Dive into SILK Ticker-Specific Updates for Smart Investing
Insider Monkey
a month ago
Simply Wall St.
a month ago
Thomson Reuters StreetEvents
a month ago
GuruFocus.com
a month ago
GuruFocus.com
a month ago
Associated Press Finance
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
The information presented on this page, "SILK Silk Road Medical Inc. - Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.